Olink
Olink
OLK
NASDAQ
26.01
USD
-0.27%
About
Olink Holding AB (publ) is a Sweden-based company engaged in the marketing and sales of biotechnological products and services. The Company offers a technique to identify actionable biomarkers, with a focus on the human plasma proteome. The Company operates in Sweden and the USA..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 1.1M |
| Three Month Average Volume | 11.2M |
| High Low | |
| Fifty-Two Week High | 26.09 USD |
| Fifty-Two Week Low | 14.1 USD |
| Fifty-Two Week High Date | 09 Jul 2024 |
| Fifty-Two Week Low Date | 03 Oct 2023 |
| Price and Volume | |
| Current Price | 26.08 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 1.69% |
| Thirteen Week Relative Price Change | 5.24% |
| Twenty-Six Week Relative Price Change | -10.71% |
| Fifty-Two Week Relative Price Change | 11.46% |
| Year-to-Date Relative Price Change | -11.31% |
| Price Change | |
| One Day Price Change | 0.31% |
| Thirteen Week Price Change | 12.66% |
| Twenty-Six Week Price Change | 4.70% |
| Five Day Price Change | 2.07% |
| Fifty-Two Week Price Change | 40.97% |
| Year-to-Date Price Change | 3.70% |
| Month-to-Date Price Change | 2.35% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 4.04284 USD |
| Book Value Per Share (Most Recent Quarter) | 3.71253 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 1.96246 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 1.77102 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.30355 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 1.36395 USD |
| Revenue Per Share (Trailing Twelve Months) | 1.37057 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.25414 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.27039 USD |
| Normalized (Last Fiscal Year) | -0.25414 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.25414 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.27039 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.25414 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.27039 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.97277 USD |
| Cash Per Share (Most Recent Quarter) | 0.87889 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.10133 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.10951 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.49799 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -100,000 |
| Cash Flow Revenue (Trailing Twelve Months) | -36 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -24.84% |
| Pretax Margin (Last Fiscal Year) | -23.53% |
| Pretax Margin (5 Year) | -99,999.99% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 67.49% |
| Gross Margin (Trailing Twelve Months) | 66.88% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -29.64% |
| Operating Margin (Trailing Twelve Months) | -33.88% |
| Operating Margin (5 Year) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -18.63% |
| Net Profit Margin (Trailing Twelve Months) | -19.72% |
| Net Profit Margin (5 Year) | -99,999.99% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 4.71% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | 18.16% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 46.38% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | -13.79% |
| EPS Change (Trailing Twelve Months) | -126.76% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 13 |
| Price to Tangible Book (Most Recent Quarter) | 15 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -83,080,000 |
| Net Debt (Last Fiscal Year) | -94,168,000 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 19 |
| Price to Sales (Trailing Twelve Months) | 19 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 6 |
| Price to Book (Most Recent Quarter) | 7 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 5 |
| Long Term Debt to Equity (Most Recent Quarter) | 5 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 4 |
| Quick Ratio (Most Recent Quarter) | 4 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 5 |
| Current Ratio (Most Recent Quarter) | 6 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -51,243,000 |
| Free Cash Flow (Trailing Twelve Months) | -62,093,000 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 5 |
| Total Debt to Equity (Most Recent Quarter) | 6 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -5.86% |
| Return on Assets (Trailing Twelve Months) | -6.11% |
| Return on Assets (5 Year) | -99,999.99% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -6.92% |
| Return on Equity (Trailing Twelve Months) | -7.02% |
| Return on Equity (5 Year) | -99,999.99% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -6.40% |
| Return on Investment (Trailing Twelve Months) | -6.54% |
| Return on Investment (5 Year) | -99,999.99% |